Optos adds Peter Kehoe to board
This article was originally published in Clinica
Executive Summary
Peter Kehoe has become a non-executive director of retinal imaging firm Optos. Dr Kehoe is an optometrist and a former member of the Board of Trustees of the American Optometric Association. He will replace Anne Glover who has retired from Optos’s board. Ms Glover was a non-executive director at the Dunfermline, UK-based company since 1996. Optos manufactures and markets retinal imaging devices that create “Optomap” images. The firm says that the Optomap is the only image that provides an ultra-widefield, 82% view of the retina.
You may also be interested in...
Alere aided by professional diagnostics sales in fourth quarter
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra and Stout to work on expandable interbody device
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe eyes portfolio expansion to help boost molecular diagnostics credentials
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals